Cytotoxic Effect of PSC 833 in Multidrug-Resistant Leukaemia Cells
Author Information
Author(s): G Lehne, HE Rugstad
Primary Institution: University of Oslo
Hypothesis
The study investigates the effect of the P-glycoprotein inhibitor PSC 833 on the proliferation of multidrug-resistant leukaemia cells.
Conclusion
PSC 833 demonstrated a discriminating cytotoxicity in multidrug-resistant leukaemia cells, indicating its potential as a therapeutic agent.
Supporting Evidence
- PSC 833 showed a dose-dependent antiproliferative effect in resistant leukaemia cells.
- Half-maximal growth inhibitory concentrations for KG1a/200 and K562/150 cells were 0.2 µM and 0.7 µM, respectively.
- Exposure to PSC 833 induced apoptosis in the resistant leukaemia cells.
Takeaway
Researchers found that a drug called PSC 833 can kill certain cancer cells that are usually resistant to treatment, which could help in fighting cancer better.
Methodology
The study used flow cytometry to assess P-glycoprotein expression and cell viability in various leukaemia cell lines treated with PSC 833.
Limitations
The study's findings may not be applicable to all cancer types, as the effects were specific to certain leukaemia cell lines.
Want to read the original?
Access the complete publication on the publisher's website